Delivery Order SPE2DB20D7066-SPE2DB25FC2FQ
Award Date
2/6/25
Potential Completion Date
2/7/25
Potential Value
$7.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,595.07 firm fixed-price delivery order is for the supply of 4,566,629,069 units of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of December 6, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $8,762.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of 4,566,705,223 units of Ondansetron HCl 8 mg tablets. The contract has an ultimate completion date of December 13, 2024 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $4,735.62, is a firm fixed-price delivery order for the supply of 4565601075 Ondansetron ODT 8 mg tablets. The contract has an ultimate completion date of August 28, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,695.23, is for the delivery of Ondansetron ODT 4 mg tablets. This is a firm-fixed-price delivery order contract with a completion date of January 23, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,707.55 firm fixed price delivery order is for the supply of 4,566,197,426 units of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of October 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,149.57 firm fixed-price delivery order contract is for the supply of 4566601590 - Ondansetron ODT 4 mg Tablets in 30-count packages. The contract has an ultimate completion date of December 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is a delivery order with a firm fixed price of $9,195.12 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ondansetron ODT 8 mg tablets in 30-count packages, with a period of performance through November 27, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,196.93 firm fixed price delivery order contract is for the supply of Ondansetron ODT 8 mg tablets. The contract has an ultimate completion date of October 30, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,742.47, is for the delivery of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of January 15, 2025 and is a firm fixed-price Delivery Order. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ondansetron ODT 8 mg tablets. The contract has a firm fixed price of $1,271.26 and an ultimate completion date of October 9, 2024. This is a delivery order contract, which is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through...